 | • レポートコード：MRC23Q36045 • 出版社/出版日：QYResearch / 2023年3月 • レポート形態：英文、PDF、81ページ • 納品方法：Eメール（2-3日） • 産業分類：医薬品 |
| Single User | ￥429,200 (USD2,900) | ▷ お問い合わせ |
| Enterprise License | ￥858,400 (USD5,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは世界のガム膿瘍薬市場について調査・分析し、世界のガム膿瘍薬市場概要、市場トレンド、主要企業別競争状況、タイプ別セグメント分析（ミノサイクリン、クロルヘキシジン、ヨウ素グリセリン）、用途別セグメント分析（病院、薬局、その他）、地域別市場規模、主要企業のプロファイルなどに関する情報を掲載しています。主要企業としては、OraPharma、Sunstar Group、Hainan Jianke Pharmaceutical、Shenzhen Nanyue Pharmaceutical、Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd.、Lion Corporation、GlaxoSmithKlineなどが含まれています。世界のガム膿瘍薬市場は、2022年にXXX米ドル、2029年にはXXX米ドルに達すると予測され、予測期間の年平均成長率はXXX％です。COVID-19とロシア・ウクライナ戦争の影響は、ガム膿瘍薬市場規模を推定する際に考慮しました。本レポートは、ガム膿瘍薬の世界市場を定量的・定性的な分析により包括的に提示し、読者がビジネス/成長戦略を策定し、市場競争状況を把握し、現在の市場における自社のポジションを分析し、ガム膿瘍薬に関するビジネス上の意思決定に役立てることを目的としています。 ・ガム膿瘍薬市場の概要 - ガム膿瘍薬のタイプ別セグメント - 世界のガム膿瘍薬市場規模：タイプ別分析（ミノサイクリン、クロルヘキシジン、ヨウ素グリセリン） - ガム膿瘍薬の用途別セグメント - 世界のガム膿瘍薬市場規模：用途別分析（病院、薬局、その他） - 世界のガム膿瘍薬市場規模予測（2018年-2029年） ・ガム膿瘍薬市場の成長トレンド - ガム膿瘍薬の地域別市場規模（2018年-2029年） - ガム膿瘍薬市場ダイナミクス - ガム膿瘍薬の業界動向 - ガム膿瘍薬市場の成長ドライバ、課題、阻害要因 ・主要企業別競争状況 - 企業別市場シェア - 世界の主要企業、業界ランキング分析 - 市場への参入、M＆A動向 ・タイプ別セグメント：ミノサイクリン、クロルヘキシジン、ヨウ素グリセリン - 世界のガム膿瘍薬のタイプ別市場規模（2018年-2023年） - 世界のガム膿瘍薬のタイプ別市場規模（2024年-2029年） ・用途別セグメント：病院、薬局、その他 - 世界のガム膿瘍薬の用途別市場規模（2018年-2023年） - 世界のガム膿瘍薬の用途別市場規模（2024年-2029年） ・ガム膿瘍薬の地域別市場規模 - 北米のガム膿瘍薬市場規模（2018年-2029年） - アメリカのガム膿瘍薬市場規模（2018年-2029年） - ヨーロッパのガム膿瘍薬市場規模（2018年-2029年） - アジア太平洋のガム膿瘍薬市場規模（2018年-2029年） - 中国のガム膿瘍薬市場規模（2018年-2029年） - 日本のガム膿瘍薬市場規模（2018年-2029年） - 韓国のガム膿瘍薬市場規模（2018年-2029年） - インドのガム膿瘍薬市場規模（2018年-2029年） - オーストラリアのガム膿瘍薬市場規模（2018年-2029年） - 中南米のガム膿瘍薬市場規模（2018年-2029年） - 中東・アフリカのガム膿瘍薬市場規模（2018年-2029年） ・主要企業のプロファイル：企業情報、事業概要、売上、動向 OraPharma、Sunstar Group、Hainan Jianke Pharmaceutical、Shenzhen Nanyue Pharmaceutical、Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd.、Lion Corporation、GlaxoSmithKline ・アナリストの観点/結論 ・調査方法とデータソース |
Highlights
The global Gum Abscess Medicine market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Gum Abscess Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Gum Abscess Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Gum Abscess Medicine in Hospital is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Gum Abscess Medicine include OraPharma, Sunstar Group, Hainan Jianke Pharmaceutical, Shenzhen Nanyue Pharmaceutical, Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd., Lion Corporation and GlaxoSmithKline, etc. In 2022, the world’s top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Gum Abscess Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Gum Abscess Medicine.
The Gum Abscess Medicine market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Gum Abscess Medicine market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Gum Abscess Medicine companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
OraPharma
Sunstar Group
Hainan Jianke Pharmaceutical
Shenzhen Nanyue Pharmaceutical
Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd.
Lion Corporation
GlaxoSmithKline
Segment by Type
Minocycline
Chlorhexidine
Iodine Glycerin
Segment by Application
Hospital
Pharmacy
Other
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Gum Abscess Medicine companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Gum Abscess Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Minocycline
1.2.3 Chlorhexidine
1.2.4 Iodine Glycerin
1.3 Market by Application
1.3.1 Global Gum Abscess Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Pharmacy
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Gum Abscess Medicine Market Perspective (2018-2029)
2.2 Gum Abscess Medicine Growth Trends by Region
2.2.1 Global Gum Abscess Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Gum Abscess Medicine Historic Market Size by Region (2018-2023)
2.2.3 Gum Abscess Medicine Forecasted Market Size by Region (2024-2029)
2.3 Gum Abscess Medicine Market Dynamics
2.3.1 Gum Abscess Medicine Industry Trends
2.3.2 Gum Abscess Medicine Market Drivers
2.3.3 Gum Abscess Medicine Market Challenges
2.3.4 Gum Abscess Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Gum Abscess Medicine Players by Revenue
3.1.1 Global Top Gum Abscess Medicine Players by Revenue (2018-2023)
3.1.2 Global Gum Abscess Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Gum Abscess Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Gum Abscess Medicine Revenue
3.4 Global Gum Abscess Medicine Market Concentration Ratio
3.4.1 Global Gum Abscess Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Gum Abscess Medicine Revenue in 2022
3.5 Gum Abscess Medicine Key Players Head office and Area Served
3.6 Key Players Gum Abscess Medicine Product Solution and Service
3.7 Date of Enter into Gum Abscess Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Gum Abscess Medicine Breakdown Data by Type
4.1 Global Gum Abscess Medicine Historic Market Size by Type (2018-2023)
4.2 Global Gum Abscess Medicine Forecasted Market Size by Type (2024-2029)
5 Gum Abscess Medicine Breakdown Data by Application
5.1 Global Gum Abscess Medicine Historic Market Size by Application (2018-2023)
5.2 Global Gum Abscess Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Gum Abscess Medicine Market Size (2018-2029)
6.2 North America Gum Abscess Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Gum Abscess Medicine Market Size by Country (2018-2023)
6.4 North America Gum Abscess Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Gum Abscess Medicine Market Size (2018-2029)
7.2 Europe Gum Abscess Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Gum Abscess Medicine Market Size by Country (2018-2023)
7.4 Europe Gum Abscess Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Gum Abscess Medicine Market Size (2018-2029)
8.2 Asia-Pacific Gum Abscess Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Gum Abscess Medicine Market Size by Region (2018-2023)
8.4 Asia-Pacific Gum Abscess Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Gum Abscess Medicine Market Size (2018-2029)
9.2 Latin America Gum Abscess Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Gum Abscess Medicine Market Size by Country (2018-2023)
9.4 Latin America Gum Abscess Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Gum Abscess Medicine Market Size (2018-2029)
10.2 Middle East & Africa Gum Abscess Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Gum Abscess Medicine Market Size by Country (2018-2023)
10.4 Middle East & Africa Gum Abscess Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 OraPharma
11.1.1 OraPharma Company Detail
11.1.2 OraPharma Business Overview
11.1.3 OraPharma Gum Abscess Medicine Introduction
11.1.4 OraPharma Revenue in Gum Abscess Medicine Business (2018-2023)
11.1.5 OraPharma Recent Development
11.2 Sunstar Group
11.2.1 Sunstar Group Company Detail
11.2.2 Sunstar Group Business Overview
11.2.3 Sunstar Group Gum Abscess Medicine Introduction
11.2.4 Sunstar Group Revenue in Gum Abscess Medicine Business (2018-2023)
11.2.5 Sunstar Group Recent Development
11.3 Hainan Jianke Pharmaceutical
11.3.1 Hainan Jianke Pharmaceutical Company Detail
11.3.2 Hainan Jianke Pharmaceutical Business Overview
11.3.3 Hainan Jianke Pharmaceutical Gum Abscess Medicine Introduction
11.3.4 Hainan Jianke Pharmaceutical Revenue in Gum Abscess Medicine Business (2018-2023)
11.3.5 Hainan Jianke Pharmaceutical Recent Development
11.4 Shenzhen Nanyue Pharmaceutical
11.4.1 Shenzhen Nanyue Pharmaceutical Company Detail
11.4.2 Shenzhen Nanyue Pharmaceutical Business Overview
11.4.3 Shenzhen Nanyue Pharmaceutical Gum Abscess Medicine Introduction
11.4.4 Shenzhen Nanyue Pharmaceutical Revenue in Gum Abscess Medicine Business (2018-2023)
11.4.5 Shenzhen Nanyue Pharmaceutical Recent Development
11.5 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd.
11.5.1 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Company Detail
11.5.2 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Business Overview
11.5.3 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Gum Abscess Medicine Introduction
11.5.4 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Revenue in Gum Abscess Medicine Business (2018-2023)
11.5.5 Jiangsu Chen Brand Bond Pharmaceutical Co., Ltd. Recent Development
11.6 Lion Corporation
11.6.1 Lion Corporation Company Detail
11.6.2 Lion Corporation Business Overview
11.6.3 Lion Corporation Gum Abscess Medicine Introduction
11.6.4 Lion Corporation Revenue in Gum Abscess Medicine Business (2018-2023)
11.6.5 Lion Corporation Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Gum Abscess Medicine Introduction
11.7.4 GlaxoSmithKline Revenue in Gum Abscess Medicine Business (2018-2023)
11.7.5 GlaxoSmithKline Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details